Pentaxim Uses, Dosage, Side Effects and more
Each single dose of 0.5 ml ampoule contains:
Diphtheria toxoid: ≥30 IUTetanus toxoid: ≥40 IUBordetella pertussis antigens toxid: 25 mcgFilamentous haemagglutinin: 25 mcgInactivated type 1 poliomyelitis virus D antigen: 40 unitsInactivated type 2 poliomyelitis virus D antigen: 8 unitsInactivated type 3 poliomyelitis virus D antigen: 32 unitsHaemophilus influenzae type b polysaccharide (conjugated to tetanus protein): 10 mcgProduction of specific antibodies to tetanus, diphtheria, and pertusis (active immunity). Conveys active immunity via stimulation of production of endogenously produced antibodies.
Diphtheriatoxoid:≥30IUTetanustoxoid:≥40IUBordetellapertussisantigenstoxid:25mcgFilamentoushaemagglutinin:25mcgInactivatedtype1poliomyelitisvirusDantigen:40unitsInactivatedtype2poliomyelitisvirusDantigen:8unitsInactivatedtype3poliomyelitisvirusDantigen:32unitsHaemophilusinfluenzaetypebpolysaccharide(conjugatedtotetanusprotein):10mcgProductionofspecificantibodiestotetanus,diphtheria,andpertusis(activeimmunity).Conveysactiveimmunityviastimulationofproductionofendogenouslyproducedantibodies.
| Attribute | Details |
|---|---|
| Trade Name | Pentaxim |
| Generic | DPT + Poliomyelitis + Haemophilus Influenzae Type B (HIB) Conjugate Vaccines |
| Weight | 0.5ml, 0.5ml/prefilled syringe, 00 |
| Type | Injection, Sc Injection |
| Therapeutic Class | Vaccines, Anti-sera & Immunoglobulin |
| Manufacturer | Sanofi Pasteur, Sanofi Bangladesh Ltd,, Sanofi Aventis (pakistan) Ltd, |
| Available Country | Bangladesh, Pakistan |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Haemophilus influenzae type B, diphtheria, tetanus, pertussis and poliomyelitis.
Dosage
Primary Vaccination: 3 doses given at an interval of 1-2 months with booster 1 year after the primary vaccination around 16-18 months of age.
How Long Does It Take to Work?
How Long Does It Take to Work? see here Pentaxim
Precaution
Fever, acute illness, progressive chronic disease.
Interaction
There are no known drug interactions and none well documented.
Pregnancy & Breastfeeding use
Pregnancy Category- C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks
Contraindication
Pain, erythema, induration, fever, irritability.
